Mirena 52 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FHGT6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,259
Award facts
- Contract value 100% obligated
- $21,259.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $21,259.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. The contract, issued on November 26, 2025, with an ultimate completion date of December 18, 2025, utilizes firm fixed-price pricing with no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide.
The PPV-G GEN V contract, awarded to DMS Pharmaceutical Group on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, encompassing a 30-month base period with three 30-month option periods. This indefinite delivery vehicle authorizes the Defense Logistics Agency to issue multiple delivery orders for branded and generic pharmaceuticals, biologics, vaccines, and medical consumables to support military healthcare operations globally. DMS Pharmaceutical Group's selection as a regional prime vendor contractor demonstrates its established capability to meet the specialized and diverse pharmaceutical requirements of the federal military medical system, with the company's performance on numerous prior delivery orders reflecting consistent execution across multiple therapeutic categories and product lines.
Quick answers
Who was awarded contract SPE2DR26FHGT6?
SPE2DR26FHGT6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26FHGT6 worth?
The government has obligated $21,259 on SPE2DR26FHGT6.
Is contract SPE2DR26FHGT6 an order under another contract?
Yes. SPE2DR26FHGT6 is a delivery order under SPE2DR25D9244, an indefinite delivery contract.
Was contract SPE2DR26FHGT6 competed?
The extent of competition for SPE2DR26FHGT6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award